Medical News

RSS

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex's biosimilar candidate to Genentech's LUCENTIS (ranibizumab injection).

10 Feb 2015

SensiQ Technologies and Inventiva set up a European Center of Excellence in surface plasmon resonance (SPR) technologies

The SPR Center of Excellence is based in Dijon, France. Inventiva’s existing pharmaceutical discovery platform will now include SensiQ SPR technology, which strengthens Inventiva’s current service offering.

10 Feb 2015

eClinicalHealth announces approval of Europe's first remote clinical study in patients with diabetes

eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, is proud to announce the Ethical Committee approval of VERKKO in Finland - Europe's first remote clinical study to include full electronic informed consent.

10 Feb 2015

Bayer materials withstand demanding conditions and meet requirements for innovative medical devices MD&M West

Increasingly, innovative medical applications place further importance on the success of the materials they use. When patients’ health, mobility and comfort are involved, reliability and durability are crucial. Bayer MaterialScience LLC steps up to the challenge offering original equipment manufacturers (OEMs) a wide range of material solutions for their medical application needs.

10 Feb 2015

Too much folic acid during pregnancy puts daughters at risk of diabetes, obesity later in life

Mothers that take excessive amounts of folic acid during pregnancy may predispose their daughters to diabetes and obesity later in life, according to a new study published today in the Journal of Endocrinology. With high dose supplements being widely available, the study calls for a need to establish a safe upper limit of folic acid intake for pregnant women.

10 Feb 2015

AirStrip, Batswadi announce strategic partnership to bring AirStrip products into Africa

AirStrip and The Batswadi Group have announced a strategic partnership to bring the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system into ten African countries, with an initial launch in South Africa.

10 Feb 2015

GI Society releases video to spread awareness about hepatitis C

As many as 350,000 Canadians could be suffering with hepatitis C, many of whom are unaware that they are infected, thus continuing to spread the virus. Although there is a vaccine to prevent the spread of the hepatitis A and hepatitis B viruses, there is no vaccine for hepatitis C. The good news is that with new treatments, hepatitis C is now a curable disease.

10 Feb 2015

Isis receives $5 million from Biogen Idec to develop drugs for neurological disorders

Isis Pharmaceuticals, Inc. announced today it has earned a $5 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder under its broad strategic collaboration with Biogen Idec to develop drugs to treat patients with neurological disorders.

10 Feb 2015

PBI announces receipt of first purchase order for new Barozyme HT48 High-throughput System

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling sample preparation solutions using pressure cycling technology ("PCT")-based instruments and consumables to the worldwide life sciences industry, today announced the receipt of the first purchase order for its new Barozyme HT48 High-throughput System.

10 Feb 2015

Synthetic Biologics reports positive results from SYN-004 Phase 1b trial to prevent C. difficile infection

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.

10 Feb 2015

Employed people who engage in voluntary work have greater sense of work-life balance

Gainfully employed people who volunteer in their spare time are healthier and more satisfied with their work-life balance than people who do not engage in voluntary work, shows a study funded by the Swiss National Science Foundation.

10 Feb 2015

Researchers reveal how the brain makes sense of data from fingers

Northwestern University and Carnegie Mellon University researchers now report a fascinating discovery that provides insight into how the brain makes sense of data from fingers.

10 Feb 2015

Combination of coconut oil and exercise training can reduce blood pressure

Coconut oil is one of the few foods that can be classified as a "superfood." Its unique combination of fatty acids can have profound positive effects on health, including fat loss, better brain function and many other remarkable benefits.

10 Feb 2015

Study findings help improve lung cancer screening guidelines

A set of guidelines developed to help standardized lung cancer screening would have generated considerably fewer false-positives than the National Lung Screening Trial produced, according to a new retrospective study.

10 Feb 2015

Excluding cancer survivors from lung cancer clinical trials may not be justified, study finds

The common practice of excluding patients with a prior cancer diagnosis from lung cancer clinical trials may not be justified, according to a study by researchers from UT Southwestern Medical Center.

10 Feb 2015

Mercury associated with autoimmunity among women of childbearing age

One of the greatest risk factors for autoimmunity among women of childbearing age may be associated with exposure to mercury such as through seafood, a new University of Michigan study says.

10 Feb 2015

Ten hospital programs recognized for improving health of local communities

From street outreach in Burlington, Vermont to a New York City taxi network to infant mortality prevention in Detroit, ten hospital programs were named Programs of Excellence for their achievements in improving the health of local communities. Each program was awarded $10,000 through the Hospital Charitable Services Awards, a national program sponsored by Jackson Healthcare.

10 Feb 2015

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.

10 Feb 2015

HPV vaccination does not affect sexual behaviours

Research has shown that human papillomavirus (HPV) vaccination is not associated with increases in sexually transmitted infections (STIs).

10 Feb 2015

Bayer offers wide range of material solutions for OEMs' medical application needs

Increasingly, innovative medical applications place further importance on the success of the materials they use. When patients' health, mobility and comfort are involved, reliability and durability are crucial. Bayer MaterialScience LLC steps up to the challenge offering original equipment manufacturers (OEMs) a wide range of material solutions for their medical application needs.

10 Feb 2015

Medical News

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

SensiQ Technologies and Inventiva set up a European Center of Excellence in surface plasmon resonance (SPR) technologies

eClinicalHealth announces approval of Europe's first remote clinical study in patients with diabetes

Bayer materials withstand demanding conditions and meet requirements for innovative medical devices MD&M West

Too much folic acid during pregnancy puts daughters at risk of diabetes, obesity later in life

AirStrip, Batswadi announce strategic partnership to bring AirStrip products into Africa

GI Society releases video to spread awareness about hepatitis C

Isis receives $5 million from Biogen Idec to develop drugs for neurological disorders

PBI announces receipt of first purchase order for new Barozyme HT48 High-throughput System

Synthetic Biologics reports positive results from SYN-004 Phase 1b trial to prevent C. difficile infection

Employed people who engage in voluntary work have greater sense of work-life balance

Researchers reveal how the brain makes sense of data from fingers

Combination of coconut oil and exercise training can reduce blood pressure

Study findings help improve lung cancer screening guidelines

Excluding cancer survivors from lung cancer clinical trials may not be justified, study finds

Mercury associated with autoimmunity among women of childbearing age

Ten hospital programs recognized for improving health of local communities

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

HPV vaccination does not affect sexual behaviours

Bayer offers wide range of material solutions for OEMs' medical application needs

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News